Figure 2: The pharma industry's sales growth with flat-line to 2014 7

Figure 3: The growing cost of drug discovery and allocation of R&D investment by function (%), 1975-2008 8

Figure 4: Productivity continues to decline across the US, Europe and Japan , 1989-2008 9

Figure 5: Top priorities of life sciences executives 10

Figure 6: PhRMA R&D as a proportion of sales (%), 1975-2008 13

Figure 7: Percent of life sciences companies' IT budgets allocated to various phases of the drug lifecycle 13

Figure 8: The impact of in silico models on drug compound testing and drug time-to-market 14

Figure 9: Current drug discovery and development process 15

Figure 10: R&D process with in silico research incorporated 18

Figure 11: Matrix of vendors that provide in silico technologies and support 24

To order this report:IT Services Industry:

More